FDA Import Refusal 102-0011728-0/41/2 — Reckitt Banckiser Plc
The FDA refused shipment 102-0011728-0/41/2 from Reckitt Banckiser Plc (United Kingdom) on Sep 27, 2021. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,330,483,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 27, 2021
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,330,483,75